Transcription of シスメックス株式会社 - sysmex-labscience.jp
1 NoncliniCal Blood Testing and Cell AnaLysis 2017 3 1 - CBC (Complete blood count) 5 DIFF 6 RET 7 8 A ADP 10 AHF 10 APTT 10 APIII 11 F FDP 11 L LACI 11 P PIC 12 PIVKA 12 PT 12 S SLE 13 T TAT 13 TFPI 13 1 14 2 14 2 15 15 15 16 16 16 2 17 17 17 17 18 18 18 18 3 19 4 19 19 A
2 19 B 19 BM 20 VIII 20 20 21 21 21 21 21 22 22 22 22 I 23 V 23 VII 23 VIII 24 IX 24 X 25 XI 26 XII 26 XIII 27 28 28 28 3 28 A2 28 29 29 29 K 29 30 30 30 31 1 42 31 32 32 32 32 33 34 34 1 35 35 35 C 35 C 36 S 36 37 37 37 38 38 38 38 38 38 4 S SOP 39 39 39 39 39 40
3 40 40 40 40 40 41 41 41 41 41 41 41 5 I 1 CBC(Complete blood count) (1) WBC White Blood Cell (2) RBC Red Blood Cell (3) HGB Hemoglobin (4) HCT (hematocrit) (5) MCV Mean Corpuscular Volume RBC HCT (6) MCH Mean Corpuscular Hemoglobin RBC HGB (7) MCHC Mean Corpuscular Hemoglobin Concentration HCT HGB (8) PLT Platelet (9) RDW-SD RBC 100% 20% RDW-SD (10) RDW-CV RBC RBC L1 L2 6 (11) PDW PLT PLT 100% 20% PDW (12) MPV LD(Lower Discriminator) UD(Upper Discriminator) MPV (13) P-LCR 12fL LD(Lower Discriminator) UD(Upper Discriminator) (14) PCT PLT 2 DIFF (1) NEUT (#, %) Neutrophil (2)LYMPH (#, %) Lymphocyte (3) MONO (#, %) Monocyte 7 (4) EO (#, %) Eosinophil (5)
4 BASO (#, %) Basophil 3 RET (1) RET Reticulocyte RET# RET% RBC (2) IRF (Immature Reticulocyte Fraction) MFR HFR (3) LFR (Low Fluorescence Ratio) HFR MFR (4) MFR (Middle Fluorescence Ratio) (5) HFR (High Fluorescence Ratio) 8 4 (1) DC RBC,HCT,PLT ( ) DC ( 3 ) DC DC DC 1983 (2) SLS-Hb HGB SLS- Sodium LaurLysulfate (C12H25SO4Na.)
5 SLS) SLS- (1) SLS (2) SLS9 (3) (4) SLS (3) DIFF,WBC/BASO,RET flow cytoMetry FCM 10 II A (1) ADP Adenosine diphosphate C10H15N5O10P2 ATP ADP GPIIb/III ADP 1 ADP ADP ADP (2) AHF Antihemophilic factor VIII VIII (3)
6 APTT ActiVated PArtial Thromboplastin Time XII PTT 1/9 11 30 45 (4) ATIII AntithrombinIII III 300 g/ml 432 58,200 Xa ATIII 393 ( ) ATIII (Arg13,Lys125, Arg46,Arg47,Lys125, Arg129,Arg132) 750 2 DIC 5,000 ATIII F (1) FDP Fibrin or Fibrinogen degradation products (1) LACI Lipoprotein associated coagulation inhibitor TFPI TFPI 12 (1)
7 PIC Plasmin 2 plasmininhibitor complex - 2 2 6 E A 2 2 PIC g/ml DIC (2) PIVKA Protein induced by vitamin K absence K K II VII IX X C S K NH2 10 Glu Gla K Gla Ca K Gla lu 3 K K K K PT 15 40 10 (3)
8 PT Prothrombin Time VII X V II 13 12 PT DIC PT 20 (1) SLE Lupus anticoagulants LA SLE ELISA APTT APTT (1) TAT Thrombin Anti-ThrombinIII Complex III III III (TAT) TAT ATIII TAT ELISA DIC DIC (2)
9 TFPI Tissue factor PAthway inhibitor LACI 2 VLDL HDL 276 3 Kunitz 42,000 4 VIIa X 2 Kunitz Xa 1 Kunitz VIIa VIIa X IX 5 100ng/ml 14 (1) 1 alpha antitrypsin 1 AT 50,000 150 350mg/dl IXa Xa 2 2 Plasmin inhibitor 2 PI 2- 67.
10 000 2- PI 2- PI C Arg364-Met365 Ser740 15 XIa 70 g/ml 1 2 2- PI 2-MG 2- PI EIA 2- 2- PI DIC , 2 2 Macroglobulin 2 MG 2 MG 1,451 180,000 4 726,000 Xa t-PA 2 MG 1 1 1 2
